Premier Alternatives

NeuroBionics

Cambridge, MA · Founded 2023 · Privately Held (backing)

Developer of a neural interface technology designed to enhance the integration of bioelectronics with the human body. NeuroBionics is based in Cambridge, MA and was founded in 2023. It was valued at $33.3 million at its seed round in Dec 2025, the last priced event on record. It has raised $9.3 million across 1 recorded round; the latest was a $4.2 million seed round in Nov 2025.

PMV mark · valuation
$33.3M
Oct 2026
Priced at
its seed round
Dec 2025
Total raised
$9.3M
Last round
Seed Round
Nov 2025

NeuroBionics key facts

as of Oct 2026
  • Developer of a neural interface technology designed to enhance the integration of bioelectronics with the human body.
  • NeuroBionics is valued at approximately $33.3M as of Oct 2026, set at its seed round, Dec 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $9.3M across 1 recorded rounds; the latest was Seed Round ($4.2M) in Nov 2025.
  • Notable investors include Pioneer Fund, Mana Ventures, MedTech Innovator, Gaingels, Greentown Labs — 19 tracked in total.
  • NeuroBionics has filed 1 Form D with the SEC, most recently Dec 2025 ($4.2M sold to 7 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$33.3M

Valued at $33.3M at its seed round, Dec 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of NeuroBionics with a free account
  • ·The complete investor list: 19 names
  • ·Watch NeuroBionics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

NeuroBionics funding rounds

1 rounds
Nov 2025Seed Round$4.2MSEC filing▮
Full funding history →

NeuroBionics valuation

NeuroBionics was valued at $33.3 million at its seed round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has NeuroBionics raised?

NeuroBionics has raised $9.3 million in total; 1 of its rounds is on record. The largest on record was a $4.2 million seed round in Nov 2025.

NeuroBionics has filed 1 Form D with the SEC, most recently in Dec 2025 ($4.2 million sold to 7 investors).

NeuroBionics investors

19 investors are on record for NeuroBionics, including Pioneer Fund, Mana Ventures, MedTech Innovator and Gaingels. By type, the record holds 9 venture capital firms. The seed round in Nov 2025 drew 7 investors.

About NeuroBionics

Developer of a neural interface technology designed to enhance the integration of bioelectronics with the human body. The company offers features such as microscale, flexible bioelectronic fibers that incorporate electrical, chemical and optical capabilities to sense and modulate biological environments, enabling researchers and medical professionals to improve therapeutic interventions and develop treatments for neurological disorders while ensuring seamless interaction with biological systems.

Sector
Healthcare
HQ
Cambridge, MA, United States
Founded
2023
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.